11:14 AM EDT, 10/15/2024 (MT Newswires) -- GSK (GSK) on Tuesday filed a lawsuit against Moderna ( MRNA ) in Delaware federal court, alleging that Moderna's ( MRNA ) COVID-19 vaccine Spikevax infringes on GSK's patent rights related to messenger RNA technology, Reuters and other media outlets reported.

The suit claims that Moderna's ( MRNA ) lipid nanoparticles, which facilitate mRNA transport into human body, violate several GSK patents covering similar innovations, the reports said.

GSK shares were up 0.4% while MRNA was down 0.2% in recent trading.

Price: 39.29, Change: +0.16, Percent Change: +0.41